Shopping Cart 0
Cart Subtotal
AED 0

NanoString Technologies Inc (NSTG) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
AED 918

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
AED 1835

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
AED 2753

Details

Summary

NanoString Technologies Inc (NanoString) is a developer of life science tools for translational research and molecular diagnostics. The company's products include sprint profiler, Dx analysis system with flex, nCounter MAX analysis system, protein assays, solid tumor assays, gene fusion panels, RNA panels, DNA assays, immunology panel, gene expression codesets, pancancer immune profiling and pathways, among others. Its nCounter MAX analysis system provides cost-effective method to profile various miRNA, miRGE or DNA molecules simultaneously employing a novel digital molecular barcoding technology. The company sells its products through direct sales force and distributors in Austria, Poland, Czech Republic, Slovakia, Hungary, Croatia, Slovenia, Bosnia Herzegovina, Serbia, Romania, Albania, Macedonia and Bulgaria, among others. NanoString is headquartered in Seattle, Washington, the US.

NanoString Technologies Inc (NSTG)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

NanoString Technologies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

NanoString Technologies Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

NanoString Technologies Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

NanoString Technologies Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

NanoString Technologies Inc, Medical Devices Deals, 2012 to YTD 2018 10

NanoString Technologies Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

NanoString Technologies Inc, Pharmaceuticals & Healthcare, Deal Details 12

Venture Financing 12

NanoString Technologies Raises USD 0.2 Million In Venture Financing 12

NanoString Technologies Raises USD 15 Million In Series E Financing 13

NanoString Technologies To Raise USD 0.65 Million In Venture Financing 15

Partnerships 16

NanoString Technologies Enters into Agreement with OHSU Knight Cancer Institute 16

NanoString Enters into Research Agreement with CITN for Novel Cancer Immunotherapies 17

NanoString Enters into Co-Development Agreement with Celgene 18

NanoString Technologies And BD Biosciences Enter Into Agreement To Develop Single Cell Isolation And Analysis Workflow 19

Licensing Agreements 20

NanoString Technologies Enters Into Option For Licensing Agreement With Massachusetts General Hospital 20

Equity Offering 21

NanoString Technologies Completes Underwriters Exercise of Over-Allotment Option of Public offering of Shares of Shares for USD57.5 Million 21

NanoString Technologies Plans to Raise up to USD40 Million in Private Placement of Shares 23

NanoString Technologies Completes Public Offering Of Shares For USD 55 Million 24

NanoString Technologies Completes IPO Of Shares For USD 54 Million 26

NanoString Technologies Inc-Key Competitors 28

NanoString Technologies Inc-Key Employees 29

NanoString Technologies Inc-Locations And Subsidiaries 30

Head Office 30

Recent Developments 31

Financial Announcements 31

Aug 07, 2018: NanoString Technologies Releases Operating Results for Second Quarter of 2018 31

Jul 16, 2018: NanoString Technologies Provides Preliminary Revenue Results for Second Quarter 2018 33

May 08, 2018: NanoString Technologies Releases Operating Results for First Quarter of 2018 34

Jan 08, 2018: NanoString Technologies Provides Preliminary Operational and Financial Results for Fourth Quarter and Fiscal Year 2017 36

Nov 02, 2017: NanoString Technologies Releases Operating Results for Third Quarter of 2017 37

Oct 11, 2017: NanoString Announces Preliminary Revenue for Third Quarter of Fiscal Year 2017 38

Aug 08, 2017: NanoString Technologies Releases Operating Results for Second Quarter of 2017 39

May 04, 2017: NanoString Technologies Releases Operating Results for First Quarter of 2017 40

Mar 01, 2017: NanoString Technologies Releases Fourth Quarter and Full Year 2016 Operating Results and Provides 2017 Outlook 41

Jan 10, 2017: NanoString Technologies Provides Preliminary Operational and Financial Results for 2016 42

Corporate Communications 43

May 10, 2017: NanoString Appoints Elisha W. Finney to Board of Directors 43

Product News 44

Apr 03, 2017: Digital Spatial Profiling Technology Enables Quantitative Protein Profiling in FFPE Tissue Providing Detailed Molecular Characterization of Immune Response to Tumors 44

Appendix 46

Methodology 46

About GlobalData 46

Contact Us 46

Disclaimer 46


List Of Figure

List of Figures

NanoString Technologies Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

NanoString Technologies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

NanoString Technologies Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

NanoString Technologies Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

NanoString Technologies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

NanoString Technologies Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7

NanoString Technologies Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

NanoString Technologies Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

NanoString Technologies Inc, Medical Devices Deals, 2012 to YTD 2018 10


List Of Table

List of Tables

NanoString Technologies Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2

NanoString Technologies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

NanoString Technologies Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

NanoString Technologies Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

NanoString Technologies Inc, Deals By Therapy Area, 2012 to YTD 2018 9

NanoString Technologies Inc, Medical Devices Deals, 2012 to YTD 2018 10

NanoString Technologies Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

NanoString Technologies Raises USD 0.2 Million In Venture Financing 12

NanoString Technologies Raises USD 15 Million In Series E Financing 13

NanoString Technologies To Raise USD 0.65 Million In Venture Financing 15

NanoString Technologies Enters into Agreement with OHSU Knight Cancer Institute 16

NanoString Enters into Research Agreement with CITN for Novel Cancer Immunotherapies 17

NanoString Enters into Co-Development Agreement with Celgene 18

NanoString Technologies And BD Biosciences Enter Into Agreement To Develop Single Cell Isolation And Analysis Workflow 19

NanoString Technologies Enters Into Option For Licensing Agreement With Massachusetts General Hospital 20

NanoString Technologies Completes Underwriters Exercise of Over-Allotment Option of Public offering of Shares of Shares for USD57.5 Million 21

NanoString Technologies Plans to Raise up to USD40 Million in Private Placement of Shares 23

NanoString Technologies Completes Public Offering Of Shares For USD 55 Million 24

NanoString Technologies Completes IPO Of Shares For USD 54 Million 26

NanoString Technologies Inc, Key Competitors 28

NanoString Technologies Inc, Key Employees 29

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies

Products

NanoString Technologies Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

Company Profile

Company Profile Title

Summary

NanoString Technologies Inc (NanoString) is a developer of life science tools for translational research and molecular diagnostics. The company's products include sprint profiler, Dx analysis system with flex, nCounter MAX analysis system, protein assays, solid tumor assays, gene fusion panels, RNA panels, DNA assays, immunology panel, gene expression codesets, pancancer immune profiling and pathways, among others. Its nCounter MAX analysis system provides cost-effective method to profile various miRNA, miRGE or DNA molecules simultaneously employing a novel digital molecular barcoding technology. The company sells its products through direct sales force and distributors in Austria, Poland, Czech Republic, Slovakia, Hungary, Croatia, Slovenia, Bosnia Herzegovina, Serbia, Romania, Albania, Macedonia and Bulgaria, among others. NanoString is headquartered in Seattle, Washington, the US.

NanoString Technologies Inc (NSTG)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Scope

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

NanoString Technologies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

NanoString Technologies Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

NanoString Technologies Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

NanoString Technologies Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

NanoString Technologies Inc, Medical Devices Deals, 2012 to YTD 2018 10

NanoString Technologies Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

NanoString Technologies Inc, Pharmaceuticals & Healthcare, Deal Details 12

Venture Financing 12

NanoString Technologies Raises USD 0.2 Million In Venture Financing 12

NanoString Technologies Raises USD 15 Million In Series E Financing 13

NanoString Technologies To Raise USD 0.65 Million In Venture Financing 15

Partnerships 16

NanoString Technologies Enters into Agreement with OHSU Knight Cancer Institute 16

NanoString Enters into Research Agreement with CITN for Novel Cancer Immunotherapies 17

NanoString Enters into Co-Development Agreement with Celgene 18

NanoString Technologies And BD Biosciences Enter Into Agreement To Develop Single Cell Isolation And Analysis Workflow 19

Licensing Agreements 20

NanoString Technologies Enters Into Option For Licensing Agreement With Massachusetts General Hospital 20

Equity Offering 21

NanoString Technologies Completes Underwriters Exercise of Over-Allotment Option of Public offering of Shares of Shares for USD57.5 Million 21

NanoString Technologies Plans to Raise up to USD40 Million in Private Placement of Shares 23

NanoString Technologies Completes Public Offering Of Shares For USD 55 Million 24

NanoString Technologies Completes IPO Of Shares For USD 54 Million 26

NanoString Technologies Inc-Key Competitors 28

NanoString Technologies Inc-Key Employees 29

NanoString Technologies Inc-Locations And Subsidiaries 30

Head Office 30

Recent Developments 31

Financial Announcements 31

Aug 07, 2018: NanoString Technologies Releases Operating Results for Second Quarter of 2018 31

Jul 16, 2018: NanoString Technologies Provides Preliminary Revenue Results for Second Quarter 2018 33

May 08, 2018: NanoString Technologies Releases Operating Results for First Quarter of 2018 34

Jan 08, 2018: NanoString Technologies Provides Preliminary Operational and Financial Results for Fourth Quarter and Fiscal Year 2017 36

Nov 02, 2017: NanoString Technologies Releases Operating Results for Third Quarter of 2017 37

Oct 11, 2017: NanoString Announces Preliminary Revenue for Third Quarter of Fiscal Year 2017 38

Aug 08, 2017: NanoString Technologies Releases Operating Results for Second Quarter of 2017 39

May 04, 2017: NanoString Technologies Releases Operating Results for First Quarter of 2017 40

Mar 01, 2017: NanoString Technologies Releases Fourth Quarter and Full Year 2016 Operating Results and Provides 2017 Outlook 41

Jan 10, 2017: NanoString Technologies Provides Preliminary Operational and Financial Results for 2016 42

Corporate Communications 43

May 10, 2017: NanoString Appoints Elisha W. Finney to Board of Directors 43

Product News 44

Apr 03, 2017: Digital Spatial Profiling Technology Enables Quantitative Protein Profiling in FFPE Tissue Providing Detailed Molecular Characterization of Immune Response to Tumors 44

Appendix 46

Methodology 46

About GlobalData 46

Contact Us 46

Disclaimer 46


List Of Figure

List of Figures

NanoString Technologies Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

NanoString Technologies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

NanoString Technologies Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

NanoString Technologies Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

NanoString Technologies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

NanoString Technologies Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7

NanoString Technologies Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

NanoString Technologies Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

NanoString Technologies Inc, Medical Devices Deals, 2012 to YTD 2018 10


List Of Table

List of Tables

NanoString Technologies Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2

NanoString Technologies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

NanoString Technologies Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

NanoString Technologies Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

NanoString Technologies Inc, Deals By Therapy Area, 2012 to YTD 2018 9

NanoString Technologies Inc, Medical Devices Deals, 2012 to YTD 2018 10

NanoString Technologies Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

NanoString Technologies Raises USD 0.2 Million In Venture Financing 12

NanoString Technologies Raises USD 15 Million In Series E Financing 13

NanoString Technologies To Raise USD 0.65 Million In Venture Financing 15

NanoString Technologies Enters into Agreement with OHSU Knight Cancer Institute 16

NanoString Enters into Research Agreement with CITN for Novel Cancer Immunotherapies 17

NanoString Enters into Co-Development Agreement with Celgene 18

NanoString Technologies And BD Biosciences Enter Into Agreement To Develop Single Cell Isolation And Analysis Workflow 19

NanoString Technologies Enters Into Option For Licensing Agreement With Massachusetts General Hospital 20

NanoString Technologies Completes Underwriters Exercise of Over-Allotment Option of Public offering of Shares of Shares for USD57.5 Million 21

NanoString Technologies Plans to Raise up to USD40 Million in Private Placement of Shares 23

NanoString Technologies Completes Public Offering Of Shares For USD 55 Million 24

NanoString Technologies Completes IPO Of Shares For USD 54 Million 26

NanoString Technologies Inc, Key Competitors 28

NanoString Technologies Inc, Key Employees 29

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products

NanoString Technologies Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.